BSIKX
Price
$9.64
Change
-$0.01 (-0.10%)
Updated
Jul 31 closing price
Net Assets
48.38B
STBJX
Price
$24.50
Change
-$0.00 (-0.00%)
Updated
Jul 31 closing price
Net Assets
1.25B
Interact to see
Advertisement

BSIKX vs STBJX

BSIKX vs STBJX Comparison Chart in %
View a ticker or compare two or three
VS
BSIKX vs. STBJX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSIKX is a Hold and STBJX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BSIKX has more cash in the bank: 48.4B vs. STBJX (1.25B). STBJX pays higher dividends than BSIKX: STBJX (5.73) vs BSIKX (4.85). BSIKX was incepted earlier than STBJX: BSIKX (10 years) vs STBJX (7 years). STBJX (1.61) is less costly to investors than BSIKX (0.64). BSIKX is a more actively managed with annual turnover of: 1006.00 vs. STBJX (190.00). STBJX has a lower initial minimum investment than BSIKX: STBJX (10000) vs BSIKX (5000000). BSIKX annual gain was more profitable for investors over the last year : 4.61 vs. STBJX (3.93). BSIKX return over 5 years is better than : 15.08 vs. STBJX (9.22).
BSIKXSTBJXBSIKX / STBJX
Total Expense Ratio0.631.6139%
Annual Report Gross Expense Ratio0.641.6140%
Fund Existence10 years7 years-
Gain YTD1.3911.025136%
Front LoadN/AN/A-
Min. Initial Investment50000001000050,000%
Min. Initial Investment IRAN/AN/A-
Net Assets48.4B1.25B3,863%
Annual Yield % from dividends4.855.7385%
Returns for 1 year4.613.93117%
Returns for 3 years20.9212.02174%
Returns for 5 years15.089.22164%
Returns for 10 years43.29N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MFMO22.470.26
+1.17%
Motley Fool Momentum Factor ETF
QDVO28.960.27
+0.94%
Amplify CWP Growth & Income ETF
FEZ69.770.07
+0.10%
State Street® SPDR® EURO STOXX 50® ETF
MMIN23.63-0.01
-0.06%
NYLI MacKay Muni Insured ETF
RXL55.10-0.73
-1.31%
ProShares Ultra Health Care